Factors Affecting the Price of Cablivi

Cablivi, a treatment for aTTP, has its price shaped by multiple elements. High R&D costs play a role, as years of research and testing are involved in creating this unique therapy. The complex production process also contributes, with specific techniques required to manufacture the drug accurately.

Factors Affecting the Price of Cablivi

Market factors matter too. Since aTTP is a rare disease, the limited patient pool restricts large - scale production, keeping prices high. Additionally, competition from alternative treatments can influence Cablivi's price positioning in the market.

Caplacizumab(Cablivi)
CABLIVI (caplacizumab-yhdp) is specifically indicated for the treatment of adult patients diagnosed with acquired thrombotic thrombocytopenic purpura (aTTP).
RELATED ARTICLES
Side Effects of Caplacizumab
Caplacizumab is a specific drug for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in...
Monday, August 25th, 2025, 13:13
Effects and efficacy of Caplacizumab

Caplacizumab is a drug specifically used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in...

Wednesday, July 9th, 2025, 16:43
/ 1
2 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved